Login

Luke J. Burchill, M.B.B.S., Ph.D. Cardiologist, Mayo Clinic 00:00:00

Share On Facebook Share On Twitter

Dr. Burchill shares his perspective on what makes Mayo Clinic’s approach to ACHD special.

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Exploring BBX Minerals' PGM Project and Bioleaching Advances with CEO Andre Duchesne
00:10:00
Expanding Horizons: The Strategic Vision of Al Sweidi Cable Company in Qatar
00:10:00
AGAT Laboratories: Core Values and Company Purpose.
00:10:00
Venteny's Digital Solutions: Elevating Employee Happiness with Fintech, Insurance, and Education | Junichiro Waide, CEO, PT Venteny Fortuna International.
00:10:00
lifelong learner and developer of talent|James Currier,General Partner,NFX
00:10:00
Taruga Minerals: Exploring High-Grade Cobalt Deposits in Congo
00:10:00
Demystifying Finance Industry Designations: CFP®, CFA, and CPA Explained | Elizabeth Hutton - VICE PRESIDENT, FINANCIAL PLANNER of Howe & Rusling, Inc.
00:10:00
Market Dynamics and Investment Plans in Greater Stockholm Amidst Ongoing Concerns | Stefan Dahlbo , CEO , Fabege AB.
00:10:00
Discover Sales Opportunities at Agilent: Passion, Innovation, and Customer Focus.
00:00:00
Christopher von Jako, CEO, Polarean Imaging
00:00:00
Ed Gudaitis, President and CEO, Acerus Pharmaceuticals Corporation
00:00:00
Invest to get the best income and growth - George Boubouras , MD, Contango Asset Management

© 2017 - Neuhu+